Pyrazolopyridazine derivatives for the treatment of hepatitis C

Details for Australian Patent Application No. 2011220915 (hide)

Owner Bristol-Myers Squibb Company

Inventors Kadow, John F.; Pracitto, Richard

Agent A J Park

Pub. Number AU-A-2011220915

PCT Pub. Number WO2011/106340

Priority 61/308,084 25.02.10 US

Filing date 23 February 2011

Wipo publication date 1 September 2011

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

11 October 2012 PCT application entered the National Phase

  PCT publication WO2011/106340 Priority application(s): WO2011/106340

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011220916-Device and system for determining, preparing and administering therapeutically effective doses

2011220909-Treatment of dermatological allergic conditions